SPRY
ARS Pharmaceuticals Inc (SPRY)
Healthcare • NASDAQ • $10.54+2.53%
Key Fundamentals
- Symbol
- SPRY
- Exchange
- NASDAQ
- Sector
- Healthcare
- Industry
- Biotechnology
- Price
- $10.54
- Daily Change
- +2.53%
- Market Cap
- $958.28M
- Trailing P/E
- N/A
- Forward P/E
- -10.08
- 52W High
- $18.90
- 52W Low
- $6.66
- Analyst Target
- $28.80
- Dividend Yield
- N/A
- Beta
- 0.83
About ARS Pharmaceuticals Inc
ARS Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes treatments for severe allergic reactions in the United States and internationally. The company is involved in the development of neffy, a needle-free intranasal delivery of epinephrine for emergency treatment of Type I allergic reactions, including anaphylaxis. ARS Pharmaceuticals, Inc. was founded in 2015 and is headquartered in San Diego, California.
Company websiteResearch SPRY on Stk-Ai
Stk-Ai gives you screening across 100+ fundamental metrics, AI-powered analysis, target predictions, backtested signals, and portfolio tracking — all in one place.
Data shown is for informational purposes only and is not investment advice. Prices and metrics may be delayed.